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Abstract
Understanding the root molecular and genetic causes driving complex traits is a fundamental challenge in genomics and
genetics. Numerous studies have used variation in gene expression to understand complex traits, but the underlying
genomic variation that contributes to these expression changes is not well understood. In this study, we developed a
framework to integrate gene expression and genotype data to identify biological differences between samples from
opposing complex trait classes that are driven by expression changes and genotypic variation. This framework utilizes
pathway analysis and multi-task learning to build a predictive model and discover pathways relevant to the complex trait of
interest. We simulated expression and genotype data to test the predictive ability of our framework and to measure how
well it uncovered pathways with genes both differentially expressed and genetically associated with a complex trait. We
found that the predictive performance of the multi-task model was comparable to other similar methods. Also, methods like
multi-task learning that considered enrichment analysis scores from both data sets found pathways with both genetic and
expression differences related to the phenotype. We used our framework to analyze differences between estrogen receptor
(ER) positive and negative breast cancer samples. An analysis of the top 15 gene sets from the multi-task model showed
they were all related to estrogen, steroids, cell signaling, or the cell cycle. Although our study suggests that multi-task
learning does not enhance predictive accuracy, the models generated by our framework do provide valuable biological
pathway knowledge for complex traits.
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Introduction
A fundamental challenge in genomics is discovering and
understanding the molecular and genetic basis of complex traits.
A deeper understanding of complex traits will potentially lead to a
better diagnosis and treatment of complex diseases. A number of
studies have used gene expression assays to model, at a molecular
level, direct influences driving phenotypic variation. A shortcom-
ing of this approach is that gene expression differences may be
driven by many genomic and environmental factors, including
underlying genetic variation [1]. In this study, we developed a
framework to integrate complementary evidence of differential
expression and genotype variation associated with a complex
phenotype. Results based on this framework aim to uncover
pathways that influence phenotype with biologically relevant
differences, specifically differential gene expression, genetic
variation, or a combination of the two. Pathways showing both
expression and genetic differences suggest that transcriptional
variation may be driven in part by genetic variation. The goal of
this framework is to better model the genetic and molecular causes
of complex traits, including complex diseases.
Several previous efforts have explored integrating different
genomic data types [2–11]. Many have focused on using gene
expression and DNA copy number data. For example, one study
modeled gene expression based on the copy number variation for
genes on the same chromosome arm [2]. Others looked for regions
with high copy number alterations and then searched for
important genes within these regions [3–6]. In one study focused
on colorectal cancer, they calculated fold changes in expression
and copy number data between normal and diseased samples,
ordered all probes based on chromosomal location, and then
searched for large chromosomal segments showing coordinated
expression and copy number changes [3]. This analysis revealed
many regions with copy number gain or loss along with differential
expression of genes in the region, and they identified several
candidate genes in regions of interest for further study.
Other studies searched for significant differences in individual
genes for multiple genomic data [7–9]. For example, one study
integrated gene expression, copy number, DNA methylation, and
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loss of heterozygosity (LOH) data for breast cancer [7]. They
looked for genes that had significant changes in all of these data
types when compared to normal. This analysis revealed that
ERBB2, an important breast cancer gene, simultaneously showed
amplification, loss of heterozygosity, loss of methylation, and a
drastic increase in gene expression.
Genome-wide association studies generally utilize genotype data
by itself, but a few studies have integrated this genotype data with
other genomic data. One study integrated genotype data with gene
expression data for various cancer types to find genes with
expression changes driven by genotype differences [10]. They
selected cancer-associated genes whose expression profiles are
known to predict treatment outcome and looked for genotype
patterns within these genes. They created a model in which
expression profiles and genotype patterns for selected genes were
combined and used to predict the treatment success of prostate
and breast cancer patients.
Some studies performed a pathway-level integrative analysis
[3,8,11]. For example, one study integrated gene expression and
somatic mutation data to identify pathways frequently altered in
prostate cancer [3]. A single tumor was considered to have an
altered pathway if one or more genes in the pathway had a somatic
mutation or had an expression level that was significantly different
than in normal prostate. Pathways altered in a large percentage of
the samples were considered frequently altered. This study
identified three well-known cancer pathways as frequently altered:
PI3K, RAS/RAF, and RB.
Our study provides a new framework for integrating different
genomic data types that consists of two key steps, sample-specific
pathway analysis and multi-task learning, that individually have
proven useful in classification analyses but have never been used
together. Most previous integrative approaches performed se-
quential or independent analyses of each data type. Our method
differs from these approaches in that genome-wide expression and
genotype data, encoded as pathway enrichment scores, are
simultaneously used to build the final predictive model. This
eliminates the restriction of using results from one independent
analysis to filter results from the other, and instead allows the
model to equally and simultaneously consider data from each
experiment.
Gene set analysis explores biological data in the context of
pathways. This approach examines the simultaneous enrichment
of multiple genes belonging to particular pathways, in contrast to
single-gene analysis, which searches for differences in individual
genes. For complex traits, many phenotypic differences are
associated with perturbations in specific pathways [12–15]. Also,
pathway analysis provides results that are highly reproducible
between studies [16,17]. Many methods have been developed to
analyze data on the gene set level [16,18–21]. In general, these
provide a single measure of enrichment for each gene set across all
samples. In order to use multi-task learning to build a predictive
model, sample-specific pathway enrichment information is re-
quired. To obtain this information, our framework extends a gene
set enrichment software package called ASSESS (Analysis of
Sample Set Enrichment ScoreS) [22], which provides a measure of
pathway enrichment for each sample.
Although gene set enrichment analysis can improve the
interpretability of results [23] and increase predictive performance
[22], an additional advantage of our pathway analysis step is
providing a method to more easily integrate data types that may
have very different structure. For example, expression data consists
of gene-based continuous values, whereas genotype data consists of
discrete SNP-based genotypes. By first obtaining sample-specific
gene set enrichment scores for each data type, this also acts as a
normalization step to allow each data type to be combined with
other data types.
Multi-task learning [24] is a supervised learning approach to
building predictive models from data that contain complementary
information. While other supervised learning methods perform
well when there is a single data type, studies have shown an
improved performance in predictive accuracy in some instances
when simultaneously building multiple models from data with
related information [24–26]. Our framework builds predictive
models using the sample-specific enrichment scores from ASSESS
for different data types. Multi-task learning provides a way to
integrate these data types as different tasks in the model. Our
framework uses regularized multi-task learning [25], which is a
Support Vector Machine (SVM) [27] implementation of multi-
task learning. Multi-task learning aims to take advantage of data
with similar information between tasks while also incorporating
information unique to each task. In the context of our pathway-
based multi-task framework, similar information means similar
pathway enrichment among data types, whereas different infor-
mation means pathway enrichment that is unique to a data type.
In order to examine the ability of multi-task learning to
simultaneously utilize similar and different pathway enrichment
properties in our study, we compared the predictive ability of
multi-task learning to single-task learning and a concatenated data
learning model. Single-task learning independently builds separate
models for each task and does not consider whether there is similar
or different information between tasks. In this study, we performed
single-task learning by independently using a standard SVM to
build a predictive model for each data type. A concatenated data
model combines all data together by simply concatenating it into a
single data set to take advantage of all information together, but it
does not distinguish which task the information originated from. In
this study, we built concatenated data models by combining all of
the enrichment scores for all data types together into a single data
set and used a standard SVM to build a single predictive model.
Multi-task learning builds a model that attempts to take
advantage of the strengths of both single-task learning and
concatenated data models. It does this by calculating a common
effect shared among all tasks (see Methods), similar to a
concatenated data model. At the same time, it determines a
task-specific effect that is unique to each task (see Methods), similar
to a single-task model. Successful multi-task learning models
should show an improvement in predicative performance when
compared to a single-task model and a concatenated data model.
The framework we describe here can integrate several different
types of genomic data with each sample having been assigned to
one of two phenotypic classes, along with a collection of gene sets.
It uses this to produce a predictive model that can also identify
gene sets important in distinguishing phenotype.
In this study, we examine the performance of this framework
under a variety of conditions, and determine how useful this
framework is for genomic data. Although our framework can be
used to integrate many different genomic data types, this study
focuses on the integration of gene expression and genotype data.
Incorporating genotype data required the development of a novel
method for obtaining sample-specific enrichment scores for this
data. To test the performance of our framework, we generated
simulated data and compared the predictive accuracy of multi-task
learning to single-task learning and a concatenated data model.
Results show that multi-task learning has a similar predictive
accuracy as the single-task learning and concatenated data models.
We also show that models that consider all tasks, such as multi-task
or concatenated data models, are better at discovering gene sets
with pathways containing genes that are both differentially
Predictive Framework for Integrating Genomic Data
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e44635
expressed and genetically associated with a phenotype. We also
used our framework to explore differences between estrogen
receptor (ER) positive and negative breast cancer. The top 15 gene
sets from the multi-task model were involved with estrogen,
steroids, cell signaling, or the cell cycle.
Results
An overview of the analysis pipeline for integrating gene
expression and genotype data within our framework is presented
in Figure 1. The two key steps are first a sample-based analysis on
the pathway level using ASSESS (Figure 1b–1c), and second the
integration of genomic data into a predictive model using a multi-
task SVM (Figure 1d).
In step one, ASSESS takes as input gene-based genomic data for
samples belonging to one of two phenotypic classes. It then
produces sample-specific enrichment scores for a collection of gene
sets. To do this, it first calculates a correlation statistic for each
gene in each sample that represents the degree to which the gene-
based data matches the summary profile of that gene in samples
from one phenotype class compared to the other (Figure 1b).
Then, it ranks all genes based on this correlation statistic for each
sample and uses gene set enrichment analysis to determine the
enrichment of pathways within samples (Figure 1c).
In step two, we use the enrichment scores from ASSESS that
are calculated independently for several different data types as the
input tasks to the multi-task model (Figure 1d). Multi-task learning
assumes that the samples among the different tasks are indepen-
dent, and it does not require that the different data come from the
same matched samples or that there are the same number of
samples in each task. In this study, we compare the performance of
multi-task models with single-task and concatenated data models.
The single-task model uses the enrichment scores from ASSESS to
build separate single-task models for each data type (Figure 2). The
concatenated model combines the enrichment scores from all data
types and builds a single model from this concatenated data set
(Figure 3).
Since these methods do not treat matched data, meaning
expression and genotype data are from the same samples,
differently from unmatched data, they may fail utilize important
information if the data is matched. To address this, we explored
models that specially consider multiple data from matched samples
that produce a single prediction for each sample. First, we used a
summed prediction model that sums the predictions from the single-
task models for each data type to obtain a single prediction for
each sample. Second, we created a summed enrichment score model
that sums the ASSESS enrichment scores for each gene set in each
sample and uses these summed enrichment scores within a single-
task model to obtain a single prediction. Third, we used a merged
model that takes enrichment scores from ASSESS for each data
type for a given sample and merges them into a single feature
vector of enrichment scores for that sample. We used these merged
enrichment scores with a single-task model to obtain a single
prediction.
ASSESS was previously developed for use with gene expression
data, but not genotype data. Therefore, we first extended ASSESS
to obtain sample-specific enrichment scores for genotype data. We
next evaluated the performance of our framework by simulating
multiple data sets to explore the following questions: 1) does the
similarity of tasks influence the predictive performance of a multi-
task model; 2) does the number of samples impact the predictive
performance; 3) does the number of tasks influence the predictive
performance; and 4) does an integrated approach improve our
ability to discover pathways that are enriched in several data types.
Finally, we applied our framework to a breast cancer data set to
analyze differences between ER+ and ER- samples.
Obtaining enrichment scores for genotype data
To facilitate the integration of genotype data with gene
expression, we extended the previously developed software
package ASSESS to obtain sample-specific gene set enrichment
scores for genotype data. A key challenge in using any gene-based
method for the analysis of genotype data is mapping the SNP-
based data to the gene level. We designed our framework to select
a single SNP to represent each gene (Figure 1a). For all SNPs
located within a predefined distance surrounding and including a
gene, we performed a Pearson’s chi-square test on each SNP to
determine its correlation with phenotype and selected the SNP
with the highest correlation as the representative SNP for that
gene.
After mapping the genotype data to the gene level, we
calculated the ASSESS correlation statistic for each sample and
gene (Figure 1b) by comparing the genotype for a sample and gene
Figure 1. Overview of the multi-task pipeline. For genotype data,
we associate each gene with a single SNP (a). Next, we calculate
correlation statistics using the gene-based data for each data type (b).
We then calculate enrichment scores using the correlation statistics for
each data type (c). Finally, we build a predictive model for each data
type in an integrative way using the enrichment scores for each data
type and a multi-task SVM (d). In this overview, ASSESS corresponds to
steps b and c.
doi:10.1371/journal.pone.0044635.g001
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to the genotypes of all samples in each class for that gene (see
Methods). We used these correlation statistics within the ASSESS
software to then obtain gene set enrichment scores (Figure 1c).
Using ASSESS for gene expression and genotype data, we obtain
similar sample-specific enrichment scores for both data types that
can be integrated in a multi-task analysis.
Predictive performance of multi-task with varying
similarity of tasks
Multi-task learning may offer an advantage when there is a
balance of similar and different pathway enrichment among
different data types. If there is too much similar enrichment, then
multi-task learning may not outperform a concatenated data
model. If the enrichment is too different, then a multi-task model
may not outperform single-task learning. To test the performance
of our multi-task framework, we created a simulation to compare
the predictive accuracy of a multi-task model to a single-task and
concatenated data model with varying similarity in the tasks.
We simulated gene expression and genotype data with gene sets
belonging to one of the following gene set types:
1. 10 genes that were differentially expressed between the two
phenotype classes and genetically associated with phenotype;
2. 10 genes that were differentially expressed but not genetically
associated;
3. 10 genes that were not differentially expressed, but genetically
associated;
4. 10 genes that were neither differentially expressed nor
genetically associated.
Figure 2. Overview of the single-task pipeline. For genotype data,
we associate each gene with a single SNP (a). Next, we calculate
correlation statistics using the gene-based data for each data type (b).
We then calculate enrichment scores using the correlation statistics for
each data type (c). Finally, we independently build a predictive model
for each data type using the enrichment scores for each data type and a
standard SVM (d). In this overview, ASSESS corresponds to steps b and
c.
doi:10.1371/journal.pone.0044635.g002
Figure 3. Overview of the concatenated data pipeline. For
genotype data, we associate each gene with a single SNP (a). Next, we
calculate correlation statistics using the gene-based data for each data
type (b). We then calculate enrichment scores using the correlation
statistics for each data type (c). We next concatenate the enrichment
scores for all data types into a single data set (d). Finally, we build a
single predictive model using the concatenated enrichment scores and
a standard SVM (e). In this overview, ASSESS corresponds to steps b and
c.
doi:10.1371/journal.pone.0044635.g003
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We generated data for 5 experimental scenarios, each with a
varied number of gene sets from each gene set type (Table 1). Data
with gene sets predominantly from gene set type 1 have similar
enrichment across tasks, while data predominantly from gene set
type 2 and 3 have different enrichment across tasks.
For each scenario, we simulated matched expression and
genotype data for 50 training samples, which were equally split
into 2 phenotypes. The data was matched such that the expression
level of a gene for a given sample was generated taking into
account the genotype of the SNP associated with that gene for that
sample (see Methods). We used our multi-task framework to train
predictive models with these samples. Then, we used these models
to obtain predictions for 50 test samples as to which phenotypic
class they belong to. We also used the same data and ASSESS-
based enrichment scores to evaluate single-task SVMs and an
SVM with the expression and genotype enrichment scores
concatenated. In addition, we used the same enrichment scores
to evaluate the summed prediction, summed enrichment score,
and merged models, which utilize matched data. We repeated this
procedure 200 times to obtain 10,000 predictions for each scenario
and calculated the percentage of correct predictions for each
scenario and SVM model type (Tables 2, 3, and 4).
For the expression data, the predictive performance was similar
for all scenarios and model types (Table 2). For the genotype data,
multi-task learning had a significant improvement in predictive
accuracy compared to the concatenated model for all scenarios,
but failed to perform better than the single-task model (Table 3).
Also, accuracy improved for the multi-task and concatenated
models as the scenarios contained more similar enrichment
(Table 3). For the models that utilize matched data, the summed
prediction and summed enrichment score models failed to perform
better than the best unmatched model, but the merged model had
a significant improvement in predictive accuracy compared to the
best unmatched model (Table 4). Although the difference in
predictive accuracy was statistically significant in some cases, the
actual predictive performance was similar in these instances.
Predictive performance of multi-task with varying
number of samples
We next determined the effect that sample size has on our
multi-task framework when compared to a single-task or
concatenated data model. To do this, we first simulated matched
expression and genotype data using gene sets from scenario 3. In
the previous analysis, we used 50 samples to train the model. In
this analysis, we varied the number of training samples from 10 to
200. As above, we used the training samples to build a multi-task,
single-task, and concatenated data model, and we simulated an
equal number of test samples to generate predictions. We also
evaluated the summed prediction, summed enrichment score, and
merged models, which utilize matched data. We repeated to
obtain 10,000 predictions for each number of samples and
calculated the percentage of correct predictions for each number
of samples and each type of model (Tables 5, 6, and 7).
For the expression data, the predictive accuracy was similar
among all model types (Table 5). For the genotype data, multi-task
learning had a significantly higher predictive performance than the
concatenated model for analyses with a sample size of 50 or more
(Table 6). However, multi-task learning did not perform better
than single-task learning for any of the sample sizes (Table 6). For
the models that utilize matched data, the merged model had a
significant improvement in predictive accuracy compared to the
best unmatched model for all sample sizes (Table 7). The summed
Table 1. Scenarios with varying similarity between tasks.
Type 1 Gene Sets Type 2 Gene Sets Type 3 Gene Sets Type 4 Gene Sets
Scenario 1 0 (0/0) 20 (20/0) 20 (0/20) 60 (0/0)
Scenario 2 5 (5/5) 15 (15/0) 15 (0/15) 65 (0/0)
Scenario 3 10 (10/10) 10 (10/0) 10 (0/10) 70 (0/0)
Scenario 4 15 (15/15) 5 (5/0) 5 (0/5) 75 (0/0)
Scenario 5 20 (20/20) 0 (0/0) 0 (0/0) 80 (0/0)
Values in parenthesis represent the number of gene sets with genes that are differentially expressed and the number of gene sets with genes that are genetically
associated, respectively. Scenario 1 contains data with most different enrichment between data types; scenario 5 contains data with most similar enrichment.
doi:10.1371/journal.pone.0044635.t001
Table 2. Performance of expression data with varying levels
of similarity.
Single-Task Multi-Task Concatenated
Scenario 1 59.58%60.52% 58.98%60.50% 58.69%60.49%
Scenario 2 59.58%60.52% 59.01%60.48% 59.06%60.50%
Scenario 3 59.58%60.52% 59.17%60.50% 59.20%60.48%
Scenario 4 59.58%60.52% 59.25%60.50% 59.34%60.49%
Scenario 5 59.58%60.52% 59.55%60.50% 59.26%60.49%
Percentage of correct predictions with standard error for the expression data
using single-task, multi-task, and concatenated models with varying levels of
similarity in the data.
doi:10.1371/journal.pone.0044635.t002
Table 3. Performance of genotype data with varying levels of
similarity.
Single-Task Multi-Task Concatenated
Scenario 1 69.26%60.47% 66.00%60.48% 62.33%60.53%
Scenario 2 69.26%60.47% 66.14%60.44% 63.23%60.50%
Scenario 3 69.26%60.47% 66.58%60.45% 63.91%60.50%
Scenario 4 69.26%60.47% 66.87%60.46% 64.53%60.48%
Scenario 5 69.26%60.47% 67.76%60.46% 65.18%60.49%
Percentage of correct predictions with standard error for the genotype data
using single-task, multi-task, and concatenated models with varying levels of
similarity in the data.
doi:10.1371/journal.pone.0044635.t003
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prediction and summed enrichment score models also had a
significantly higher predictive performance than the best un-
matched model for the analysis with a sample size of 10 (Table 7).
As expected, the predictive accuracy improved as the number of
samples increased for all model types, but multi-task learning did
not appear to benefit more than the other model types.
Predictive performance of multi-task with varying
number of tasks
We also evaluated the effect of varying the number of tasks. We
generated expression data sets, each corresponding to a task, with
20 training samples evenly divided into 2 phenotypes. We
simulated phenotype associated gene sets with 10 genes that were
differentially expressed between the phenotypes, and background
gene sets with 10 genes that represented a null model of random
expression. We generated a task by simulating the first 30 gene sets
as phenotype associated gene sets and the next 20 gene sets as
background. For the last 50 gene sets, 30 were randomly chosen to
be phenotype associated and the other 20 background. We
generated additional tasks in the same way. As a result, the first 50
gene sets contained similar enrichment among all tasks, and the
last 50 gene sets contained enrichment unique to each task. We
used this data to build multi-task models with the number of tasks
used to build each model varying from 2 to 100. We also used this
data one task at a time to build single-task models for comparison.
After using the 20 training samples for each task to train the
model, we used 20 test samples for each task to obtain predictions.
We repeated to obtain 10,000 predictions for each number of tasks
and determined the percentage of correct predictions for each
number of tasks (Figure 4). We also performed the same analysis
with simulated genotype data (Figure 5). For the genotype data,
phenotype associated gene sets contained genes that were
genetically associated and background gene sets contained genes
that were not genetically associated.
For the expression data, the predictive accuracies of all multi-
task models and of the single-task model showed no significant
difference (Figure 4). For the genotype data, the predictive
performance of the multi-task experiments with 10 tasks or less
was not significantly different than the single-task model (Figure 5).
However, multi-task models with 20 tasks or more had a
significantly lower predictive accuracy than the single-task model
(Figure 5). Although this suggests that analyses with a large
number of tasks may have a significant difference in performance
between multi-task learning and single-task learning, most analyses
of biological data will have a small number of different data types
or tasks. For these data, our multi-task framework may not be
significantly different than single-task in terms of predictive
accuracy.
Finding pathways enriched across multiple data types
In addition to being used for class prediction of unknown
samples, we can analyze the trained models to determine whether
this integrative approach provides an improved ability to discover
gene sets enriched across multiple data types. A predictive weight
for each gene set can be derived from the predictive model that
results from an SVM analysis (see Methods). Gene sets with higher
weights contribute more to prediction, and also may be more
important in distinguishing phenotype. After training a multi-task
SVM model, a common weight can be derived that is interpreted
as a measure of importance for prediction derived from all tasks
(see Methods). Gene sets with larger common weights can be
viewed as sharing common information important for prediction
across all tasks. These gene sets may represent biological pathways
with important factors in multiple data types that are influencing
Table 4. Performance of matched data models with varying levels of similarity.
Summed Prediction Summed Enrichment Score Merged
Scenario 1 67.97%60.52% 67.87%60.46% 71.19%60.47%
Scenario 2 67.97%60.52% 67.99%60.44% 71.19%60.47%
Scenario 3 67.97%60.52% 68.11%60.46% 71.19%60.47%
Scenario 4 67.97%60.52% 68.68%60.48% 71.19%60.47%
Scenario 5 67.97%60.52% 68.53%60.49% 71.19%60.47%
Percentage of correct predictions with standard error using summed prediction, summed enrichment score, and merged models with varying levels of similarity in the
data.
doi:10.1371/journal.pone.0044635.t004
Table 5. Performance of expression data with varying sample
sizes.
Single-Task Multi-Task Concatenated
10 Samples 56.47%60.46% 55.85%60.47% 55.72%60.48%
20 Samples 58.15%60.53% 58.33%60.51% 58.26%60.51%
50 Samples 59.10%60.54% 59.02%60.50% 59.16%60.50%
100 Samples 61.00%60.49% 61.26%60.47% 61.20%60.53%
200 Samples 63.67%60.54% 63.10%60.56% 62.74%60.54%
Percentage of correct predictions with standard error for the expression data
using single-task, multi-task, and concatenated models with varying sample
sizes.
doi:10.1371/journal.pone.0044635.t005
Table 6. Performance of genotype data with varying sample
sizes.
Single-Task Multi-Task Concatenated
10 Samples 55.10%60.49% 56.06%60.47% 56.02%60.48%
20 Samples 62.52%60.49% 62.93%60.47% 62.05%60.48%
50 Samples 70.84%60.47% 69.02%60.45% 65.11%60.51%
100 Samples 76.50%60.45% 74.10%60.48% 70.28%60.54%
200 Samples 82.50%60.53% 80.19%60.50% 74.91%60.56%
Percentage of correct predictions with standard error for the genotype data
using single-task, multi-task, and concatenated models with varying sample
sizes.
doi:10.1371/journal.pone.0044635.t006
Predictive Framework for Integrating Genomic Data
PLOS ONE | www.plosone.org 6 September 2012 | Volume 7 | Issue 9 | e44635
phenotype. We designed the following simulation to determine the
ability of our framework to discover this type of gene set.
We simulated matched expression and genotype data for 400
samples that were evenly divided into 2 phenotypes. This data
contained the same gene set types as the first simulation study. We
created this data set with 1 of gene set type 1 (the target gene set), 5
of gene set type 2, 5 of gene set type 3, and 89 of gene set type 4.
We wanted to test the ability of our framework to extract the one
target gene set, which contains genes that are both differentially
expressed and genetically associated. We used our framework to
train multi-task, single-task, and concatenated data predictive
models. For multi-task, we determined the rank of the common
weight in the predictive model for the target gene set. For single-
task, we calculated the rank of the weight in the predictive model
for the target gene set in the expression model and the genotype
model separately. For the concatenated data model, we calculated
the rank of the target gene set in a single predictive model built by
concatenating the enrichment scores of the expression and
genotype data. We also took the sum of the weights for both
single-task models and determined the rank of the combined
weight for the target gene set. In addition, we trained the summed
enrichment score and merged predictive models. For the summed
enrichment score model, we calculated the rank of the target gene
set in a single predictive model built by taking the sum of the
enrichment scores from the expression and genotype data. For the
merged model, we built a single predictive model by taking the
enrichment scores from the expression and genotype data and
merging them into a single feature vector for each sample. We
then took the sum of the expression and genotype weights for each
gene set and determined the rank of the combined weight for the
target gene set. We repeated this analysis 1000 times and
calculated the average rank for each model type (Table 8).
The average rank for the target gene set was significantly lower
in all models that considered both tasks (single-task summed,
multi-task, concatenated, summed enrichment score, and merged)
compared to either of the separate single-task models (Table 8).
This suggests that an integrated approach may be beneficial for
Table 7. Performance of matched data models with varying sample sizes.
Summed Prediction Summed Enrichment Score Merged
10 Samples 59.19%60.48% 58.57%60.49% 59.20%60.48%
20 Samples 63.45%60.50% 63.86%60.49% 64.03%60.52%
50 Samples 68.60%60.46% 69.03%60.50% 72.57%60.45%
100 Samples 74.34%60.46% 74.77%60.49% 79.42%60.46%
200 Samples 80.44%60.57% 81.35%60.50% 86.05%60.44%
Percentage of correct predictions with standard error using summed prediction, summed enrichment score, and merged models with varying sample sizes.
doi:10.1371/journal.pone.0044635.t007
Figure 4. Performance of expression data with varying number of tasks. The solid line represents the change in predictive accuracy as the
number of tasks changes, with the error bars being standard error. The middle dashed line represents the predictive accuracy of a single-task model
with one task, with the outer dashed lines being standard error.
doi:10.1371/journal.pone.0044635.g004
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discovering biological pathways that have an important effect
within several genomic data types.
Analysis of breast cancer data set
To provide support for the usefulness of our framework in
identifying phenotypically relevant pathways, we applied it to
matched expression and genotype data for breast invasive
carcinomas (BRCA) generated through The Cancer Genome
Atlas (TCGA) project. This data set contained 61 samples that
were classified as estrogen receptor (ER) negative and 203 samples
that were ER positive. Our collection of gene sets was compiled
from the curated canonical pathways in the Molecular Signatures
Database (MSigDB) [16]. We filtered these gene sets to only
include those with 15 to 100 mapped genes, resulting in 538 gene
sets.
First, we wanted to determine the ability of the data to predict
ER status. We performed leave-one-out (LOO) cross-validation to
calculate predictive accuracy for multi-task, single-task, concate-
nated, summed prediction, summed enrichment score, and
merged models (Tables 9, 10, and 11). For the expression data,
the predictive performance was very high for all model types, both
with respect to overall accuracy and positive and negative
predictive values (Table 9). For the genotype data, the overall
predictive performance was moderate, but the negative predictive
value (NPV) was low (Table 10). For the models that utilize
matched data, the predictive accuracy was moderately better than
using the genotype data alone, but not better than using the
expression data alone (Table 11). The negative predictive value
was greatly improved for the models that utilize matched data
when compared to using the genotype data alone (Table 11).
These results suggest that important gene sets in the predictive
models may be biologically relevant to ER status.
We next examined gene sets with the highest weights in the
predictive models for their biological relevance to ER status. To
allow for a direct comparison of the predictive weights among
gene sets, we first normalized the enrichment scores from ASSESS
(see Methods). We calculated the ranks of all gene sets for multi-
task, single-task, concatenated, summed enrichment score, and
merged models. A complete list of all ranks and weights for all
gene sets and model types is presented in Tables S1 and S2. It is
interesting to note that the ranks vary considerably among all
models types. This includes significant differences between the
multi-task model that considers all data simultaneously and the
expression single-task and genotype single-task models which
consider only data from one data type. This suggests that using an
Figure 5. Performance of genotype data with varying number of tasks. The solid line represents the change in predictive accuracy as the
number of tasks changes, with the error bars being standard error. The middle dashed line represents the predictive accuracy of a single-task model
with one task, with the outer dashed lines being standard error.
doi:10.1371/journal.pone.0044635.g005
Table 8. Average rank of target gene set.
Average Rank
Single-Task Expression Weight 11.0160.47
Single-Task Genotype Weight 4.1760.10
Single-Task Weights Summed 3.0760.16
Multi-Task Common Weight 3.0860.16
Concatenated Weight 2.8960.14
Summed Enrichment Score Weight 3.5460.11
Merged Weights Summed 2.8760.10
Average rank with standard error in single-task, multi-task, concatenated,
summed enrichment score, and merged models for a gene set containing
genes that are both differentially expressed and genetically associated with
phenotype.
doi:10.1371/journal.pone.0044635.t008
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integrative approach provides results distinct from analyses of
either data type alone.
A list of the top 15 gene sets with the highest common weight in
the multi-task model is presented in Table 12, along with the
corresponding rank of the gene sets in the expression single-task
and genotype single-task models. The common weight from the
multi-task model can be interpreted as the importance in
distinguishing phenotype drawn from both tasks simultaneously,
whereas the ranks in the single-task models provide a way to
estimate the contribution that each data type had in the overall
integrated rank of the gene set. An analysis of the top 15 gene sets
from the multi-task model showed they were related to estrogen,
steroids, cell signaling, or the cell cycle, discussed in more detail
below. This provides support for the usefulness of our framework
in identifying pathways associated with complex traits.
Estrogen plays an important role in breast cancer [28]. We
found that three of the top 15 gene sets were directly related to
estrogen signaling and metabolism: ‘‘HER2 Pathway’’ (rank 1),
‘‘Phase II Conjugation’’ (rank 2), and ‘‘Nuclear Receptor
Transcription’’ (rank 13). Human epidermal growth factor
receptor 2 (HER2), encoded by the gene ERBB2, influences the
expression and activity of the estrogen receptor [29]. The ‘‘HER2
Pathway’’ gene set contains the estrogen receptor 1 (ESR1) gene.
The ‘‘Nuclear Receptor Transcription’’ gene set also contains the
ESR1 gene, and nuclear receptor coactivators are thought to
participate with the estrogen receptor pathway [30]. Several phase
II conjugating enzymes are involved with the metabolism of
estrogen [31]. Tamoxifen is an antiestrogenic drug that is widely
used in the treatment of ER positive breast cancer [32]. One study
showed that genetic variation in several phase II conjugating
enzymes influenced the efficacy of Tamoxifen therapy in breast
cancer [33]. Since this study linked genotype differences to
Tamoxifen efficacy, it is interesting to note that the Phase II
Conjugation gene set has the sixth highest genotype single-task
weight (Table 12) and is the highest ranked gene set in the multi-
task genotype model (w2, Table S1). It is also the eleventh highest
gene set in the single-task expression model (Table 12) and has the
fourth highest rank in the multi-task expression model (w1, Table
S1). This suggests that genotype differences may be directly
influencing expression changes. The strong association in both the
expression and genotype data resulted in the second highest rank
in the multi-task common weights (Table 12), which is higher than
the weight in either of the single-task models alone. All three of the
estrogen-related gene sets contained genes that were generally
overexpressed in the ER positive samples.
Estrogen is a steroid hormone, and we found that four of the top
15 gene sets were involved with the synthesis or metabolism of
steroids: ‘‘Steroid Hormone Biosynthesis’’ (rank 3), ‘‘Steroid
Biosynthesis’’ (rank 8), ‘‘Cholesterol Biosynthesis’’ (rank 9), and
‘‘Steroid Metabolism’’ (rank 15). In addition to estrogen, other
steroid hormones, such as progesterone, play an important role in
breast cancer [28]. Also, many steroids, including estrogen, are
synthesized from cholesterol, and one study showed that
cholesterol levels are linked with breast cancer prognosis [34].
The estrogen receptor participates in cellular signaling initiated
by the binding of estrogen and facilitating the activation of
downstream processes. In addition to the estrogen-related
pathways, three of the top 15 gene sets were similarly involved
with other types of cell signaling: ‘‘FRS2-Mediated Cascade’’ (rank
4), ‘‘Neurotransmitter Release Cycle’’ (rank 6), and ‘‘ECM-
Receptor Interaction’’ (rank 12). The FRS2-mediated cascade
links Fibroblast Growth Factor Receptor (FGFR) to the eventual
activation of several important signaling pathways. One study
showed that blocking FGFR inhibited breast cancer proliferation
and led to downregulation of the MAPK and PI3K pathways [35].
Also, ECM receptors may participate in the control of many stages
of breast cancer [36], and neurotransmitters may influence the
metastasis of breast tumors [37]. All three of these cell signaling
gene sets contained genes that were generally overexpressed in the
ER positive samples.
Tumors accumulate genetic damage that results in a perturbed
cell cycle which increases the number of tumor cells by stimulating
cell birth or inhibiting cell death or cell-cycle arrest [12]. Many of
the previously discussed gene sets are involved with the cell cycle
or metabolism, and we found that the five remaining gene sets in
the top 15 were also involved with the cell cycle and metabolism:
‘‘One Carbon Pool by Folate’’ (rank 5), ‘‘Nitrogen Metabolism’’
(rank 7), ‘‘Apoptotic Signaling in Response to DNA Damage’’
(rank 10), ‘‘Riboflavin Metabolism’’ (rank 11), and ‘‘Mitotic
Prometaphase’’ (rank 14). Disrupting mitotic prometaphase may
influence cell-cycle arrest, and disrupting apopototic signaling in
response to DNA damage may inhibit the cell death of tumor cells.
Table 9. Correct predictions for breast cancer expression data.
Single-Task Multi-Task Concatenated
Overall Accuracy 92.42% (244/264) 92.05% (243/264) 92.05% (243/264)
Positive Predictive Value 94.63% (194/205) 95.05% (192/202) 95.05% (192/202)
Negative Predictive Value 84.75% (50/59) 82.26% (51/62) 82.26% (51/62)
Percentage of correct predictions for the breast cancer expression data using single-task, multi-task, and concatenated models.
doi:10.1371/journal.pone.0044635.t009
Table 10. Correct predictions for breast cancer genotype data.
Single-Task Multi-Task Concatenated
Overall Accuracy 77.65% (205/264) 78.41% (207/264) 78.79% (208/264)
Positive Predictive Value 81.03% (188/232) 81.74% (188/230) 82.10% (188/229)
Negative Predictive Value 53.13% (17/32) 55.88% (19/34) 57.14% (20/35)
Percentage of correct predictions for the breast cancer genotype data using single-task, multi-task, and concatenated models.
doi:10.1371/journal.pone.0044635.t010
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Also, folate, nitrogen, and riboflavin, also known as vitamin B2,
are important for cell growth. One study linked increased
consumption of folate and B vitamins with reduced risk of breast
cancer [38].
Discussion
Although the simulation study showed that our integrative
framework provided an improved ability to discover pathways that
are enriched over multiple data types, multi-task learning
performed about the same as similar integrated learning methods.
Also, the predictive accuracy of multi-task learning was practically
the same as similar learning methods. All of these results suggest
that while an integrated pathway approach may be useful for
discovering relevant pathways, it may not be necessary to use
multi-task learning for most studies. Further research should
explore alternative prediction methods.
This study focused on the integration of gene expression and
genotype data. However, our framework may also be suitable for
other genomic data types, such as copy number variation and
DNA methylation. Also, the sample-specific enrichment scores
from multiple data types can be used for many sample-level
pathway-based analyses, such as clustering to find subtypes of
samples with similar pathway enrichment profiles.
Results from this study indicate that a pathway-based integra-
tive analysis is a promising approach to identify pathways that are
influenced by both gene expression changes and genotype
variation. All of the top 15 pathways from the multi-task model
built using breast cancer data have been previously associated with
breast cancer. This suggests that an integrative approach may be
useful for discovering pathways related to complex diseases,
especially diseases that are not as well understood, and for
determining the contribution that each data type has for each
pathway. The ‘‘Phase II Conjugation’’ gene set is an example that
had a strong association in both the expression and genotype data,
and this gene set had the second highest multi-task common
weight, which was higher than in either of the single-task models
alone. This supports the use of an integrative approach in
discovering gene sets that may have a direct link between genotype
and expression.
Materials and Methods
Our integrative framework contains two keys steps: 1) pathway
enrichment analysis using ASSESS and 2) building a predictive
model using an SVM. This framework is designed for integrating
different genomic data types into a predictive model for samples
that have been designated into one of two phenotypic classes.
Pathway Enrichment
ASSESS. To perform the gene set analysis step of our
framework, we used a software package called ASSESS [22].
Table 11. Correct predictions using matched data models for breast cancer data.
Summed Prediction Summed Enrichment Score Merged
Overall Accuracy 85.98% (227/264) 88.26% (233/264) 83.71% (221/264)
Positive Predictive Value 86.40% (197/228) 89.81% (194/216) 85.40% (193/226)
Negative Predictive Value 83.33% (30/36) 81.25% (39/48) 73.68% (28/38)
Percentage of correct predictions for the breast cancer data using summed prediction, summed enrichment score, and merged models.
doi:10.1371/journal.pone.0044635.t011







HER2 Pathway 1 1 368
Phase II Conjugation 2 11 6
Steroid Hormone Biosynthesis 3 7 29
FRS2-Mediated Cascade 4 10 26
One Carbon Pool by Folate 5 2 152
Neurotransmitter Release Cycle 6 53 3
Nitrogen Metabolism 7 3 225
Steroid Biosynthesis 8 23 13
Cholesterol Biosynthesis 9 21 34
Apoptotic Signaling in Response to DNA Damage 10 19 131
Riboflavin Metabolism 11 35 12
ECM-Receptor Interaction 12 164 1
Nuclear Receptor Transcription 13 50 18
Mitotic Prometaphase 14 121 4
Steroid Metabolism 15 8 154
Gene sets with the largest multi-task common weights in the breast cancer analysis, along with the ranks of the expression and genotype single-task weights.
doi:10.1371/journal.pone.0044635.t012
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ASSESS takes gene-based genomic data along with phenotype
information and provides a measure of the variation of gene set
enrichment over all samples for a given gene set. First, ASSESS
computes a correlation statistic for each sample and gene as
cij ~ log
P( xij [C1 D x
i
j ,fx1j ,:::, xnj g
P( xij [C2 D x
i
j ,fx1j ,:::, xnj g
 !
where xij is data for the i-th sample and j-th gene, and C1 and C2
are the two phenotypic classes. Next, ASSESS independently uses
the correlation statistics for each sample to compute enrichment
scores for each gene set using a weighted Kolmogorov-Smirnov
statistic. The original implementation of ASSESS includes two
metrics for calculating correlation statistics for expression data.
Normalizing the Enrichment Scores. To normalize the
original enrichment scores, we permuted the class labels and
recalculated new background enrichment scores 1000 times. If the
original enrichment score for a sample and gene set was positive,
this score was divided by the average of the positive background
enrichment scores for that sample and gene set. If the original
enrichment score was negative, this score was divided by the
absolute value of the average of the negative background
enrichment scores.
Extension of ASSESS for Genotype Data. To calculate
gene set enrichment scores for genotype data, we extended
ASSESS. The first step is associating SNP-based genotype data
with genes. To do this, we first identify all SNPs that are within a
pre-defined distance surrounding and including a given gene.
Then, we use Person’s chi-square test to determine the extent to
which each SNP correlates with phenotype. Finally, we select the
SNP that has the maximum correlation with phenotype as the
‘‘representative’’ SNP for that gene. After obtaining gene level









j is the percentage of samples with the genotype of the i-
th sample for the j-th gene in class 1, and p
g2
j is the percentage of
samples with this genotype in class 2. If either class contains zero
samples with a given genotype, a pseudo-count of 1 is added.
These correlation statistics are then used to obtain enrichment
scores in the same way as ASSESS.
Predictive Model
SVM Framework. To perform the predictive modeling step
of our framework, we used a software package called SVM-Light
[39]. All single-task and concatenated analyses use a standard
linear kernel. The SVM trains a predictive model by calculating
nonnegative Lagrange multipliers for each sample, ai. These






where C is a regularization parameter, yi is the class assignment of
the i-th sample and xi is data for the i-th sample.
Multi-Task SVM. To utilize a multi-task framework, we used
regularized multi-task learning [25], which is an implementation
of an SVM that incorporates multi-task learning. We used SVM-







where m is a positive parameter that controls the relatedness of the
models, and dst = 1 if s and t belong to the same task, dst = 0
otherwise. The SVM trains a predictive model by calculating
nonnegative Lagrange multipliers for each sample and task, ait.
These sample weights are used to derive task-specific effects for









where C is a regularization parameter, yit is the class assignment of
the i-th sample in task t, and xit is data for the i-th sample in task t.








where T is the number of tasks. The common weights are summed
with the task-specific effects for each gene set and task to compute
the final predictive weights.
Simulated Data
We simulated data similar to a previous study that integrated
gene expression and genotype data for pathway analysis [40]. For
analyses using matched data, the genotype used to generate the
expression value for a sample was used as the genotype data for
that sample.
Genotype. Each genotype data set contained genes that were
either genetically associated or had a random genotype. We
mapped genes that were genetically associated to a single causal
SNP, and we mapped genes that had a random genotype to a
single random SNP. We simulated the causal SNPs based on
parameters estimated from genotype information for glioblastoma
generated through The Cancer Genome Atlas (TCGA) project
[11]. We based these SNPs on the P53PATHWAY, as defined in
version 2.5 of the Molecular Signatures Database (MSigDB) [16].
First, we mapped a single SNP in the glioblastoma data to each of
the genes in the P53PATHWAY. To do this, we found the SNPs
within the region 1,000 bases upstream of the transcription start
site to the end of the transcribed region of each gene. Then, we
selected the SNP with minor allele frequency greater than 0.05
that had the highest chi-square association with glioblastoma. We
set the allele frequencies of the causal SNPs in the simulated data
to that of these selected SNPs in the glioblastoma data. We
generated the heterozygote odds ratio for each SNP from
U[1.1,1.3] and used an additive disease model with a disease
prevalence of 0.02. Using these parameter settings, we generated
genotype data using PLINK [41]. We determined the probability
that each sample belongs to class 1 based on the following model:




j bj z ei
where N is the number of causal SNPs, gij is the coding of the
genotype of the i-th sample for the j-th SNP, bj is the log of the
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heterozygote odds ratio for the j-th SNP, and ei is an error term for
the i-th sample drawn from a standard normal distribution. We
randomly assigned each sample to either class 1 or class 2, with the
probability of being assigned to class 1 equal to the probability
calculated in the model above. We also generated random
genotype data using PLINK. For the random genotype data, we
drew allele frequencies from Beta(0.1,0.1) and assigned a
heterozygote odds ratio of 1.
Gene Expression. Each gene expression data set contained
genes that were either differentially expressed or had random
expression. We simulated the expression data based on the TCGA
glioblastoma study. We based genes that were differentially
expressed on the P53PATHWAY. We calculated the mean vector
m and the covariance matrix S of the genes in the P53PATH-
WAY. We used this to generate baseline expression levels by
drawing from a multivariate normal distribution, X0,N(m,S). We
added a disease effect to these genes by linking each gene to a










0 is the baseline expression of the i-th sample for the j-th
gene, gij is the coding of the genotype of the i-th sample for the j-th
SNP, and bij is the effect size of the genotype on gene expression
that is drawn from U[1.0,1.5]. We also generated random
expression data. We calculated the mean of all genes in the
glioblastoma data and took the average of these means as m0 and
determined the standard deviation of all genes and the average as
s0. We used these parameters to generate random expression
levels by drawing from a normal distribution, X,N(m0, s02).
Breast Cancer Data
We obtained breast invasive carcinoma (BRCA) data generated
through The Cancer Genome Atlas (TCGA) project from their
data portal (http://cancergenome.nih.gov). We selected samples
that provided matched gene expression and genotype data. We
filtered samples to only include patients who were white, female,
40 to 70 years of age at initial diagnosis, and had a known estrogen
receptor (ER) status of positive or negative. We also eliminated the
sample with barcode ‘‘TCGA-A2-A0CY’’ because of unreliable
genotype data. This resulted in a data set of matched gene
expression and genotype data for 61 ER negative samples and 203
ER positive samples.
Supporting Information
Table S1 Rank of predictive weights in breast cancer
analysis. Rank of the predictive weights for the breast cancer
data using multi-task, single-task, concatenated, summed enrich-
ment score, and merged models.
(XLSX)
Table S2 Predictive weights in breast cancer analysis.
The predictive weights for the breast cancer data using multi-task,




We would like to thank The Cancer Genome Atlas (TCGA) consortium for
access to the breast cancer gene expression and genotype data.
Author Contributions
Conceived and designed the experiments: BDB SM TSF. Performed the
experiments: BDB. Analyzed the data: BDB SM TSF. Contributed
reagents/materials/analysis tools: QX. Wrote the paper: BDB SM TSF.
References
1. Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common
diseases and complex traits. Nat Rev Genet 6: 95–108.
2. Menezes RX, Boetzer M, Sieswerda M, van Ommen GJ, Boer JM (2009)
Integrated analysis of DNA copy number and gene expression microarray data
using gene sets. BMC Bioinformatics 10: 203.
3. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, et al. (2006)
Relationship of gene expression and chromosomal abnormalities in colorectal
cancer. Cancer Res 66: 2129–2137.
4. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010)
Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11–22.
5. Hawthorn L, Luce J, Stein L, Rothschild J (2010) Integration of transcript
expression, copy number and LOH analysis of infiltrating ductal carcinoma of
the breast. BMC Cancer 10: 460.
6. Liu F, Park PJ, Lai W, Maher E, Chakravarti A, et al. (2006) A genome-wide
screen reveals functional gene clusters in the cancer genome and identifies
EphA2 as a mitogen in glioblastoma. Cancer Res 66: 10815–10823.
7. Chari R, Coe BP, Wedseltoft C, Benetti M, Wilson IM, et al. (2008) SIGMA2: a
system for the integrative genomic multi-dimensional analysis of cancer
genomes, epigenomes, and transcriptomes. BMC Bioinformatics 9: 422.
8. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray
analysis reveals a major direct role of DNA copy number alteration in the
transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99:
12963–12968.
9. Lee H, Kong SW, Park PJ (2008) Integrative analysis reveals the direct and
indirect interactions between DNA copy number aberrations and gene
expression changes. Bioinformatics 24: 889–896.
10. Glinsky GV (2006) Integration of HapMap-based SNP pattern analysis and gene
expression profiling reveals common SNP profiles for cancer therapy outcome
predictor genes. Cell Cycle 5: 2613–2625.
11. Cancer Genome Atlas Research Network (2008) Comprehensive genomic
characterization defines human glioblastoma genes and core pathways. Nature
455: 1061–1068.
12. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control.
Nat Med 10: 789–799.
13. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. (2007) The genomic
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